Annual ARVO Report
ARVO: Cornea
From improved transplant procedures to scleral and bandage lenses, this year’s research focused on optimized corneal health.
05/15/2013
ARVO: Glaucoma
Researchers presented fresh data on new structural metrics, visual fields, blood flow and the latest glaucoma drug.
05/15/2013
ARVO: Retina
It’s an exciting time in the retina field. Researchers at ARVO 2013 reported on newly identified genetic factors in AMD and novel treatments for the disease, as well as FDA approval of a retinal prosthesis for RP and a new anti-VEGF agent for wet
05/15/2013
ARVO: Cataract & Refractive Surgery
Much of this year’s research focused upon surgical refinement and improved postoperative care.
05/15/2013
14th Annual Report from ARVO
Topics covered at this year’s meeting range from corneal transplant outcomes to the eagerly-awaited results of AREDS2.
05/15/2013
Retina
Findings this year include the results of new therapeutic regimens, the advances in imaging, and a greater understanding of the genetics behind AMD.
05/18/2009
Report from ARVO
05/18/2009
Cataract & Refractive Surgery
This year at ARVO, investigators present findings on cataract surgery risks, the importance of good nutrition and IOL-based drug delivery systems.
05/18/2009
Cornea
This year’s research includes studies on possible new dry eye indicators and treatments, contact lens solution efficacy and the lifelong impact of keratoconus.
05/18/2009
Glaucoma
This year, researchers present their findings on gene mapping, the relation of blood flow to the glaucomatous process and surgical success rates.
05/18/2009
Upcoming Events
December 5, 2024
Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Nate Lighthizer, OD, and Dagny Zhu, MD
Webinar: 9:00pm ET
Sponsored by Bausch + Lomb
December 6-7, 2024
December 7-8, 2024
Retina Update 2024
Location: Westin Carlsbad, Carlsbad, California
Program Chairs: Mohammad Rafieetary, OD, and Steven Ferrucci, OD
Earn up to 11 LIVE COPE credits (accreditation pending)
Job of the Week
